Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Wallin

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Chest|December 1, 1985
Beta-adrenergic blockers in the hypertensive asthmatic patient?J D Wallin
Journal of the National Medical Association|March 1, 1987
Refractory hypertension: patient types, special problems, and approaches to therapyJ D Wallin
Journal of Clinical Hypertension|March 1, 1986
Hypertension in black patients. Epidemiologic and pathophysiologic considerationsJ D Wallin
The American Journal of Medicine|October 17, 1983
Antihypertensives and their impact on renal functionJ D Wallin
Journal of Clinical Hypertension|June 1, 1985
Adrenoreceptors and renal functionJ D Wallin
American Heart Journal|February 1, 1990
Intravenous nicardipine hydrochloride: treatment of patients with severe hypertensionJ D Wallin
New Horizons (Baltimore, Md.)|February 1, 1996
Calcium antagonists and the kidneyC J Pearce, J D Wallin
Journal of Clinical Pharmacology|December 1, 1989
Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activityJ D Wallin, W H Frishman
Archives of Internal Medicine|March 1, 1983
Labetalol. Current research and therapeutic statusJ D Wallin, W M O'Neill
Geriatrics|April 1, 1987
Managing the elderly patient with both hypertension and pulmonary diseaseN K Krane, J D Wallin
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Chest|December 1, 1985
Beta-adrenergic blockers in the hypertensive asthmatic patient?J D Wallin
Journal of the National Medical Association|March 1, 1987
Refractory hypertension: patient types, special problems, and approaches to therapyJ D Wallin
Journal of Clinical Hypertension|March 1, 1986
Hypertension in black patients. Epidemiologic and pathophysiologic considerationsJ D Wallin
The American Journal of Medicine|October 17, 1983
Antihypertensives and their impact on renal functionJ D Wallin
Journal of Clinical Hypertension|June 1, 1985
Adrenoreceptors and renal functionJ D Wallin
American Heart Journal|February 1, 1990
Intravenous nicardipine hydrochloride: treatment of patients with severe hypertensionJ D Wallin
New Horizons (Baltimore, Md.)|February 1, 1996
Calcium antagonists and the kidneyC J Pearce, J D Wallin
Journal of Clinical Pharmacology|December 1, 1989
Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activityJ D Wallin, W H Frishman
Archives of Internal Medicine|March 1, 1983
Labetalol. Current research and therapeutic statusJ D Wallin, W M O'Neill
Geriatrics|April 1, 1987
Managing the elderly patient with both hypertension and pulmonary diseaseN K Krane, J D Wallin
Pageof 10